Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Airway Obstruction Study
2017-000893-12Phase 3Unknown
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mometasone in deviated nasal septum (DNS), perennial rhinitis and nasal airway obstruction (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: SNOT-22 total score. Status: unknown.
02
Drugs
mometasone
03
Conditions
deviated nasal septum (DNS)perennial rhinitisnasal airway obstruction
Beyond the preview
Go deeper on 2017-000893-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000893-12.